Mohammad Farhad
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Galectins and Cancer Biology
- Immune Cell Function and Interaction
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
Papers in
-
- Galectins and Cancer Biology 4
- Immunotherapy and Immune Responses 3
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
- Metal complexes synthesis and properties 1
- Co-authors
- William L. Redmond (7 shared papers)Annah S. Rolig (1 shared paper)Rachel Slottke (1 shared paper)Jeremy Cetnar (1 shared paper)George Thomas (1 shared paper)Julie N. Graff (1 shared paper)Raymond C. Bergan (1 shared paper)Joshi J. Alumkal (1 shared paper)
- Journals
- The Journal of Immunology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Proceedings of the National Academy of Sciences (1 paper)ChemMedChem (1 paper)OncoImmunology (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Mohammad Farhad
7 papers receiving 511 citations
Peers
Comparison fields: 5 of 43
- Immunology 274
- Oncology 229
- Pulmonary and Respiratory Medicine 173
- Cancer Research 49
- Molecular Biology 106
Countries citing papers authored by Mohammad Farhad
This map shows the geographic impact of Mohammad Farhad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Farhad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Farhad more than expected).
Fields of papers citing papers by Mohammad Farhad
This network shows the impact of papers produced by Mohammad Farhad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Farhad. The network helps show where Mohammad Farhad may publish in the future.
Co-authors
The 18 scholars most cited alongside Mohammad Farhad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 269 | |
| 2 | 2018 | 163 | |
| 3 | 2016 | 67 | |
| 4 | 2009 | 8 | |
| 5 | 2015 | 8 | |
| 6 | 2016 | 3 | |
| 7 | 2018 | 1 | |
| 8 | 2025 | 0 | |
| 9 | 2015 | 0 |
About Mohammad Farhad
Mohammad Farhad is a scholar working on Immunology, Oncology, Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine, having authored 9 papers that have together received 519 indexed citations. Recurring topics across this work include Galectins and Cancer Biology (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (2 papers), Cancer Mechanisms and Therapy (1 paper), Glycosylation and Glycoproteins Research (1 paper), Metal complexes synthesis and properties (1 paper) and Ferrocene Chemistry and Applications (1 paper). The work is most often cited by research in Immunology (274 citations), Oncology (229 citations), Pulmonary and Respiratory Medicine (173 citations), Cancer Research (49 citations) and Molecular Biology (106 citations). Mohammad Farhad has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include William L. Redmond, Annah S. Rolig, Rachel Slottke, Jeremy Cetnar, George Thomas, Julie N. Graff, Raymond C. Bergan, Joshi J. Alumkal, Tomasz M. Beer and Charles G. Drake. Their work appears in journals such as The Journal of Immunology, Journal for ImmunoTherapy of Cancer, Proceedings of the National Academy of Sciences, ChemMedChem and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.